Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Rare versus common diseases: a false dichotomy in precision medicine

24 Feb 2021

Abstract excerpt

Precision medicine initiatives are being launched worldwide, each with the capacity to sequence many thousands to millions of human genomes. At the strategic planning level, all are debating the extent to which these resources will be directed towards rare diseases (and cancers) versus common diseases. However, these are not mutually exclusive choices. The organizational and governmental infrastructure created...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to CRISPR and Genetic Engineering
Share to Genetic factors in colorectal cancer
Share to Genomics and Rare Diseases

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 33627657
DOI: 10.1038/s41525-021-00176-x

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Rare versus common diseases: a false dichotomy in precision medicinePMID 33627657Read ↗

The rare-to-common disease journey: a winding road to new therapies.Semantic proximity Read ↗

Precision medicine in rare diseases: What is next?Semantic proximity Read ↗

Precision Medicine and Rare Genetic Variants.Semantic proximity Read ↗

Precision Medicine for Continuing Phenotype Expansion of Human Genetic Diseases.Semantic proximity Read ↗

Whole-genome sequencing as a first-tier diagnostic framework for rare genetic diseasesSemantic proximity Read ↗

The genetics of common diseases: 10 million times as hard.Semantic proximity Read ↗

The shifting model in clinical diagnostics: how next-generation sequencing and families are altering the way rare diseases are discovered, studied, and treated.Semantic proximity Read ↗

Are we prepared to deliver gene‐targeted therapies for rare diseases?Semantic proximity Read ↗

Rare-disease genetics in the era of next-generation sequencing: discovery to translation.Semantic proximity Read ↗

From genomic advances to public health benefits: the unbearable lightness of being stuck.Semantic proximity Read ↗

eRAM: encyclopedia of rare disease annotations for precision medicine.Semantic proximity Read ↗

Patients with rare diseases: from therapeutic orphans to pioneers of personalized treatments.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.